3-D-printed drug carrier shows promise; Swiss, South Korean pharma companies sign drug delivery pact;

> South Korean researchers announced positive results from their test of a 3-D-printed drug and cell carrier for local and sustained delivery of cyclosporine A. "The improved load-bearing capacity of the combined microsphere and hydrogel system, and its ability to maintain its integrity and shape during the implantation period, helped to deliver a sustained CsA release, preventing the acceleration of the secretion of cytokines related to immune rejection," said Dr. Dong-Woo Cho of the Department of Mechanical Engineering at Pohang University of Science and Technology. More

> Switzerland's Ferring Pharmaceuticals announced that it has a signed a deal with South Korea's CTCBIO Inc. to acquire the rights to a novel oral drug delivery technology. Release

> Not-for-profit preclinical research institute CBSET said its study found that the use of Cardiovascular Systems' Diamondback 360 orbital atherectomy device improved drug absorption in calcified peripheral arteries. Release

Suggested Articles

J&J has new data that should convince regulators to clear its subcutaneous Darzalex in another indication—widening its edge over a Sanofi rival.

Genentech's Port Delivery System with ranibizumab matched Lucentis eye injections in a late-stage, wet age-related macular degeneration trial.

Honeywell aims to wean the industry of its glass habit with Aclar Edge, a new line of bottles and vials made with the company's patented plastic.